已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

嵌合抗原受体 CD19 T细胞 细胞因子释放综合征 医学 细胞因子 白血病 抗原 癌症研究 免疫学 药理学 持久性(不连续性) 免疫系统 工程类 岩土工程
作者
Sara Ghorashian,Anne Marijn Kramer,Shimobi Onuoha,Gary Wright,Jack Bartram,Rachael T. Richardson,Sarah J. Albon,Joan Casanovas-Company,Fernanda Castro,Bilyana Popova,Krystle Villanueva,Jenny Yeung,Winston Vetharoy,Aleks Guvenel,Patrycja Wawrzyniecka,Leila Mekkaoui,Gordon Weng-Kit Cheung,Danielle Pinner,Jan Chu,Giovanna Lucchini,Clóvis A. Silva,Oana Ciocârlie,Arina Lazareva,Sarah Inglott,Kimberly Gilmour,Gulrukh Ahsan,Mathieu Ferrari,Somayya Manzoor,Kim Champion,Tony Brooks,Andre Lopes,Allan Hackshaw,Farzin Farzaneh,Robert Chiesa,Kanchan Rao,Denise Bonney,Sujith Samarasinghe,Nicholas Goulden,Ajay Vora,Paul Veys,Rachael Hough,Robert Wynn,Martin Pulé,Persis Amrolia
出处
期刊:Nature Medicine [Springer Nature]
卷期号:25 (9): 1408-1414 被引量:443
标识
DOI:10.1038/s41591-019-0549-5
摘要

Chimeric antigen receptor (CAR)-modified T cells targeting CD19 demonstrate unparalleled responses in relapsed/refractory acute lymphoblastic leukemia (ALL)1-5, but toxicity, including cytokine-release syndrome (CRS) and neurotoxicity, limits broader application. Moreover, 40-60% of patients relapse owing to poor CAR T cell persistence or emergence of CD19- clones. Some factors, including the choice of single-chain spacer6 and extracellular7 and costimulatory domains8, have a profound effect on CAR T cell function and persistence. However, little is known about the impact of CAR binding affinity. There is evidence of a ceiling above which increased immunoreceptor affinity may adversely affect T cell responses9-11. We generated a novel CD19 CAR (CAT) with a lower affinity than FMC63, the high-affinity binder used in many clinical studies1-4. CAT CAR T cells showed increased proliferation and cytotoxicity in vitro and had enhanced proliferative and in vivo antitumor activity compared with FMC63 CAR T cells. In a clinical study (CARPALL, NCT02443831 ), 12/14 patients with relapsed/refractory pediatric B cell acute lymphoblastic leukemia treated with CAT CAR T cells achieved molecular remission. Persistence was demonstrated in 11 of 14 patients at last follow-up, with enhanced CAR T cell expansion compared with published data. Toxicity was low, with no severe CRS. One-year overall and event-free survival were 63% and 46%, respectively.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
张大猛完成签到,获得积分20
3秒前
3秒前
3秒前
彩色德天发布了新的文献求助10
4秒前
呼叫外星人完成签到,获得积分10
5秒前
不许人间见白头完成签到,获得积分10
7秒前
天空城主发布了新的文献求助10
7秒前
烂漫小蝴蝶完成签到,获得积分20
8秒前
丘比特应助哈哈采纳,获得10
9秒前
邓希静完成签到 ,获得积分10
9秒前
10秒前
烂漫以冬完成签到,获得积分10
10秒前
10秒前
大白发布了新的文献求助20
12秒前
naych完成签到,获得积分10
13秒前
18秒前
Hollow完成签到,获得积分10
20秒前
英姑应助科研通管家采纳,获得10
21秒前
科研通AI2S应助科研通管家采纳,获得10
21秒前
彭于晏应助科研通管家采纳,获得10
21秒前
打打应助科研通管家采纳,获得10
22秒前
orixero应助科研通管家采纳,获得10
22秒前
科目三应助科研通管家采纳,获得10
22秒前
FashionBoy应助科研通管家采纳,获得10
22秒前
23秒前
24秒前
桐桐应助bingbing34采纳,获得10
24秒前
哈哈发布了新的文献求助10
25秒前
虞方超发布了新的文献求助10
27秒前
wlq发布了新的文献求助10
28秒前
顾一刀发布了新的文献求助10
28秒前
28秒前
张大猛发布了新的文献求助10
28秒前
29秒前
英勇的数据线完成签到,获得积分20
31秒前
充电宝应助fei采纳,获得10
31秒前
32秒前
bingbing34发布了新的文献求助10
35秒前
动听凝安发布了新的文献求助10
35秒前
彩色德天完成签到 ,获得积分10
35秒前
高分求助中
Sustainability in Tides Chemistry 2000
The ACS Guide to Scholarly Communication 2000
Studien zur Ideengeschichte der Gesetzgebung 1000
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Threaded Harmony: A Sustainable Approach to Fashion 810
Pharmacogenomics: Applications to Patient Care, Third Edition 800
Free Will in the Flesh 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3081353
求助须知:如何正确求助?哪些是违规求助? 2734041
关于积分的说明 7531449
捐赠科研通 2383454
什么是DOI,文献DOI怎么找? 1263852
科研通“疑难数据库(出版商)”最低求助积分说明 612420
版权声明 597560